Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
November 21, 2023 13:53 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite Announces Exercise of Warrants for Cash Proceeds of $10 Million
December 20, 2021 16:05 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite BioPharma Announces Pricing of $5 Million Public Offering
February 10, 2020 14:48 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite BioPharma Announces $6 Million Registered Direct Offering
May 20, 2019 14:06 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...